Skip to content

Teleflex TFX Surgical — Net revenues

Other product segments

Vascular
$236.81M+8.1%
Interventional
$204.66M+104%

Similar metrics at other companies

Medline, Inc.
 logo
MDLNSurgical Solutions — Net Sales
$1.55B+7.4%
Bausch + Lomb logo
BLCOSurgical — Total revenues
$228M+6.5%
The Cooper Companies, Inc. logo
COOOffice and surgical — Net Sales
$214.2M+4.1%
Edwards Lifesciences logo
EWSurgical — Net Sales
$276.2M+10.1%
Johnson & Johnson logo
JNJSURGICAL — Sales to customers (Note 9)
$396M+9.7%
Stryker logo
SYKInstruments — Net Sales
$920M+9.8%

Other financials

Income statement

See full
Revenue$548.3M+32.3%
Gross profit$307.4M+20.4%
Operating income$20.2M-73.4%
Net income-$8.2M-109%
EPS (diluted)-$0.18-109%

Balance sheet

See full
Cash & equivalents$329.6M+16.8%
Total debt$2.8B+38.6%
Total equity$3.1B-24.7%
Total assets$6.8B-5.3%

Cash flow

See full
Operating cash flow$46.7M+68.3%
CapEx$18.8M-22.1%
Free cash flow$27.9M+676%

Valuation

See full
Market cap$5.62B-14.4%

Profitability

See full
Gross margin38.2%-3.0pp
Operating margin3%-11.8pp
Net margin-47.4%-56.2pp
FCF margin7.9%

Returns & leverage

See full
Return on equity-28.1%-31.6pp
Debt / equity0.9×+0.4×
Current ratio2.6×+0.3×

Where this comes from

Reported directly by Teleflex in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Teleflex’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Teleflex's surgical — net revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Teleflex's surgical — net revenues?
Teleflex (TFX) reported surgical — net revenues of $106.79M in Q1 2026.
How has Teleflex's surgical — net revenues changed year-over-year?
Teleflex's surgical — net revenues increased by 12.4% year-over-year, from $94.98M to $106.79M.
What is the long-term trend for Teleflex's surgical — net revenues?
Over 4 years (2021 to 2025), Teleflex's surgical — net revenues has grown at a 1.9% compound annual growth rate (CAGR), from $377.76M to $407.35M.
What does surgical — net revenues mean?
This metric represents the total gross sales generated by the surgical product segment after accounting for returns, allowances, and discounts. It reflects the market demand and commercial performance of the company's surgical instruments and related medical devices used in clinical procedures. Tracking this revenue stream provides insight into the segment's contribution to overall corporate growth and its competitive positioning within the medical device market.